The unique history of Wilson Sonsini Goodrich & Rosati closely traces the birth and evolution of Silicon Valley.
For more than 60 years, Wilson Sonsini has represented technology pioneers associated with virtually every milestone innovation, as well as life sciences trailblazers shaping the future of healthcare.
Today, the firm is synonymous with ushering promising, innovative companies through their business life cycle.
Careers
We look for the best and brightest of tomorrow and develop careers from the ground up.
News and Featured Insights
Leading Matters
Client Highlights
Wilson Sonsini Advises Solcoa Industries on $75 Million Financing
On September 24, 2026, Solcoa Industries, a rare earth metals producer, announced $75 million in financing to build Solcoa One, its first commercial rare earth metalmaking plant. The round includes $45 million in equity led by Bain Capital Ventures, with participation from Gigascale Capital, Long Journey, Felicis, Dylan Field, and prominent leaders across defense and technology. It also includes $30 million in debt and equipment financing, anchored by J.P. Morgan. Wilson Sonsini Goodrich & Rosati advised Solcoa on the transaction.
Client Highlights
Wilson Sonsini Advises Type One Energy on $200 Million Series B
On October 6, 2026, Type One Energy, the global fusion power plant developer, announced the successful completion of a $200 million Series B financing round. The financing was co-led by Breakthrough Energy Ventures and Clutterbuck Capital, with participation from Lowercarbon Capital, Siemens Energy Ventures, SiteGround Capital, and other new investors. Wilson Sonsini Goodrich & Rosati advised Type One Energy on the transaction.
The financing supports Type One Energy’s FusionDirect™ technology development program and continued execution of Project Infinity toward the world’s first commercial fusion plant at the Tennessee Valley Authority’s Bull Run site in east Tennessee. It also advances Type One Energy’s fusion industrialization strategy of building best-in-class partnerships across the value chain. This approach—differentiated within the fusion industry—applies the proven energy industry growth model to fusion and brings together the financing, manufacturing, engineering, and operational capabilities required to rapidly deploy commercial fusion at global scale.
The Wilson Sonsini team that advised Type One Energy on the transaction included Michael Danaher, Brett Schulman, Angela Chan, Sophia Kunthara, and Chelsea Gahran.
The financing supports Type One Energy’s FusionDirect™ technology development program and continued execution of Project Infinity toward the world’s first commercial fusion plant at the Tennessee Valley Authority’s Bull Run site in east Tennessee. It also advances Type One Energy’s fusion industrialization strategy of building best-in-class partnerships across the value chain. This approach—differentiated within the fusion industry—applies the proven energy industry growth model to fusion and brings together the financing, manufacturing, engineering, and operational capabilities required to rapidly deploy commercial fusion at global scale.
The Wilson Sonsini team that advised Type One Energy on the transaction included Michael Danaher, Brett Schulman, Angela Chan, Sophia Kunthara, and Chelsea Gahran.
Client Highlights
Firm Advises TypeSafe AI on $870M Series A Led by a16z at $7.5B Valuation
On October 9, 2026, TypeSafe AI, a company building machine-native AI models, announced it raised a $870 million Series A at a $7.5 billion valuation led by a16z. Sequoia Capital, existing investor DCVC, and other angel investors also participated in the round. Wilson Sonsini Goodrich & Rosati advised TypeSafe AI on the transaction.
Client Highlights
Wilson Sonsini Advises Vesta on $30 Million Series B
On October 8, 2026, Vesta, an AI-native loan origination system for mortgage lenders, announced a $30 million Series B funding led by Conversion Capital. Three Vesta customers, New American Funding, Pennymac, and nbkc bank, also invested, as did Citi Ventures, FirstKey Mortgage, and Navitas Capital. Existing investors Andreessen Horowitz, Zigg Capital, and Parker89, First American Financial's venture arm, also participated. Wilson Sonsini Goodrich & Rosati advised Vesta on the transaction.
Client Highlights
Firm Advises Voltus on Oversubscribed $225 Million Series D
On October 8, 2026, Voltus, a leading distributed energy resource platform, announced it raised $225 million in an oversubscribed Series D financing round. Generation Investment Management led the round alongside co-leads Activate Capital and Vitol. Other investors include Broadscale Group, Climate Investment, NGP, Ajax Strategies, and All Aboard Fund. Wilson Sonsini Goodrich & Rosati advised Voltus on the transaction.
Client Highlights
Wilson Sonsini Advises Atrium Therapeutics on Patent Matters Related to $50 Million Private Placement
On October 8, 2026, Atrium Therapeutics, a biopharmaceutical company advancing precision cardiology by developing RNA therapeutics targeted to the heart, announced that it has entered into a securities purchase agreement with a group of leading institutional investors for a private placement financing. The financing is expected to result in aggregate gross proceeds of approximately $50 million, before deducting placement agent fees and other offering expenses. Wilson Sonsini Goodrich & Rosati advised Atrium Therapeutics on patent matters related to the transaction.
The Life Sciences Report – June 2026
This latest edition features articles on accelerating new therapies under the new FDA administration, cash-pay healthcare companies possibly facing kickback and fee-splitting risk under federal and state laws, building in-house legal teams for biotech, digital health, and medical devices companies, and life sciences venture financings for firm clients across 1H2025.